Podcasts about jain

In this episode, host Shikha Jain, MD, speaks with Elisabeth Potter, MD, about physicians pushing back against insurance companies, bringing physicians back into positions of autonomy and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Potter 1:41 •    The interview 2:04 •    How did you decide to become a plastic surgeon? What was your path?  2:26 •    How many years do you have to train for plastic surgery? 3:36 •    What kind of physician is your father? […] Did you ever think you wanted to practice in the same field as him? 4:10 •    Can you tell us about what happened that led you to post your recent viral video? 6:11 •    Have you noticed an increase in insurance obstacles lately, or has it always been this way? 8:45 •    When you talk to insurance companies, do you feel like you speak with someone who is qualified to understand these claims? 10:06 •    Other than hiring people to deal with insurance claims, how can we work towards actually driving change in this space? 12:11 •    Jain and Potter on the value of physicians knowing their worth and the cost of their care/procedures. 16:03 •    Jain and Potter on the importance of physician autonomy. 23:21 •    Potter and Jain on the changing national dialogue. 28:48 •    When it comes to direct care models, how would patients be able to get second opinions? 33:53 •    Are you optimistic that we will be able to realistically drive change? 35:37 •    What do you suggest physicians, patients and advocates do to raise their voices and be heard? 35:56 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 40:14 •    How to contact Potter 40:41 •    Thanks for listening 41:38 Elisabeth Potter, MD, is a board-certified plastic surgeon offering a variety of plastic surgery, ranging from breast reconstruction to breast and body cosmetic procedures. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Potter can be reached on Instagram @drelisabethpotter, TikTok @drelisabethpotter and YouTube @DrElisabethPotterMD. Disclosures: Jain and Potter report no relevant financial disclosures. 

For years, disease diagnosis and treatment have focused on a few biomarkers, overlooking thousands of vital biological signals. Despite biotech advances, most therapies are still based on limited data, missing countless breakthroughs.Multiomics changes that. By analyzing tens of thousands of proteins, metabolites, and lipids, it reveals hidden insights, paving the way for smarter, faster, and more effective medical discoveries.In this must-listen episode, David Brühlmann welcomes Mo Jain, founder and CSO of Sapient, a pioneering force in bringing multiomic platforms out of academia and into the heart of drug development. A physician-scientist by training and a visionary entrepreneur by choice, Mo's journey spans decades at the cutting edge of analytical technologies, culminating in the creation of ultra-high-throughput systems that analyze up to 20,000 biomarkers in a single run for real-world impact.Here are three reasons why this episode needs to be on your playlist:Multiomics at Scale: Mo shares how his team at Sapient turbocharged mass spectrometry, enabling simultaneous measurement of thousands of molecules, transforming routine diagnostics and making previously unimaginable insights accessible to scientists everywhere.Turning Data into Action: Generating vast data is only half the battle. Mo explains how Sapient developed advanced biocomputational teams and frameworks to extract actionable answers, guiding drug developers to faster, smarter decisions and helping avoid the pitfalls that cripple so many omics projects.The Future Is Personalized and Sooner Than You Think: From dramatically earlier disease detection to truly personalized therapies, Mo paints an optimistic picture of a coming era where AI, multiomics, and new therapeutic modalities rapidly accelerate both discovery and delivery, reshaping how biotech companies tackle even the toughest diseases.Ready to break out of the 20-biomarker rut and see what 20,000 data points can reveal? Tune in to discover how you can harness multiomics in your own research and hear Mo's advice for scientists and entrepreneurs venturing beyond the bench.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

What if the secret to truly personalized precision medicine lies not in your genetic code, but in your zip code?For years, biotech has focused on genomics to explain disease and drug response, but DNA only accounts for a fraction of the story. The real breakthrough? Multi-omics: the large-scale analysis of proteins, metabolites, and lipids, powered by advanced mass spectrometry and AI, offering a fuller picture of human health.In this episode, David Brühlmann meets Mo Jain, founder and CSO of Sapient, a leader in multi-omics analytics. With over two decades of experience across physiology, biomedicine, and computational biology, Mo has been at the forefront of developing scalable multi-omics technologies that are changing the way we predict, diagnose, and treat disease. From leading an academic lab to building a pioneering biotech company, Mo's journey reflects a passion for uncovering the hidden 80–90% of disease risk that lies beyond our genes.Here are three reasons you'll want to listen to this episode:Your Environment Matters More Than Your Genes: Mo explains why your zip code is a stronger predictor of your health than your genetic code, challenging the industry's long-held beliefs and opening new avenues for disease prevention and risk assessment.Multi-omics Disrupts Drug Development: Discover how integrating thousands of biological data points can revolutionize drug discovery by identifying novel targets, better predicting drug response, and accelerating therapeutic breakthroughs that were previously out of reach.Big Data Finally Becomes Actionable: Thanks to rapid advances in mass spectrometry and computational power, scientists can now make sense of overwhelming volumes of multi-omic data, turning what was once information overload into actionable insights for diagnostics and drug development.Ready to think beyond your genes? The biotech revolution is here, and it starts in your neighborhood.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

Today I am chatting with Aashita Jain,About the privacy career she maintains.Aashita used to live in Bangalore,We will talk about Informatica and all the jobs she had before!

Today, Ali is talking to Dr. Nirali Jain, a Reproductive Endocrinologist at RMA, about the importance of fertility preservation for cancer patients. "I do feel like the system failed us a little bit, and I tell all my patients when they come in for their first visit, your entire life, you learned how to not get pregnant, and you never thought you'd be sitting in this office learning about timed intercourse and figuring out when you're ovulating," Dr. Jain says. Ali and Dr. Jain talk about how chemo can affect fertility, what your options are when you get a cancer diagnosis, and how to get a referral to a fertility specialist from your oncologist. If you or anyone you know has recently been diagnosed with cancer and you're interested in preserving your fertility, this is a must listen! Spread the word!  Follow Dr. Jain on IG: @eggspert_mdTOPICS COVERED IN THIS EPISODE: Cancer; chemotherapy; chemo agents; egg quality; egg freezing; embryo freezing; advocacy; trying to conceive; timed intercourse; ovulation EPISODE SPONSORS: BEAUTIFUL BIRD AND WORK OF ARTAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “Beautiful Bird” tells the story of three parents, one incredible boy and a family built with love—and a little bit of science.Pre-orders are available now! The first 150 copies will be Personalized, Signed and Numbered! Don't miss out on this limited edition! Tap the link in bio and stories to order your copy today.When Helen decides to have a baby on her own, she welcomes Jack Bird into the world through IUI with the help of her friend, Aaron. But when Jack is born and needs extra care in the NICU, Aaron and his partner, Blake, fall in love with Jack, too. Together, the three join forces to raise Jack, proving that family isn't about how you start—it's about how you grow.Order yours now at https://www.infertileafgroup.com/booksFor bulk orders of 10 or more books at 20% off, go to https://www.infertileafgroup.com/bulk-order-requestFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipGENERATIONS CRYOVAULTwww.gencryo.comIG: @generationscryovaultWhen you're navigating fertility treatments, every decision feels big—because it is big. But did you know that when it comes to storing your reproductive tissue—including eggs, sperm, and embryos—you DO have a choice? Most clinics automatically store your tissues—or hand you off to their partner. But guess what? It doesn't have to be that way. Enter Generations CryoVault, which believes in the motto, "Your tissues. Your choice." When you choose to work with Generations CryoVault, they help you transfer your tissues securely and easily to their headquarters – a place you can trust. Take control of this part of your journey by visiting gencryo.com. And make sure to mention Infertile AF to receive 1 free month of storage.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacySupport this podcast at https://redcircle.com/infertile-af/donationsOur Sponsors:* Check out Happy Mammoth and use my code INFERTILEAF for a great deal: https://happymammoth.comSupport this podcast at — https://redcircle.com/infertile-af/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of Grownlearn, I'm joined by Nick Jain, founder of Content Hurricane, an AI-powered content engine that's changing how startups and small businesses scale their organic traffic. Nick shares how early users of his platform saw 80%+ increases in inbound leads in just 10 weeks, and how one of his own brand-new domains shot to the top 0.1% of all new websites on Google — in just 4 weeks. We go deep on: Why traditional SEO is dying (and what's replacing it) How Content Hurricane creates high-quality, evergreen blog posts using AI Real-world strategies for scaling inbound traffic The future of SEO, AI-generated content, and business growth If you're building a startup, scaling a business, or want content that actually drives results — this is a must-listen. Try Content Hurricane (Beta)

Ed Parcaut welcomes Nick Jain, CEO of IdeaScale, to the Inner Edison Podcast for an inspiring conversation about entrepreneurship, leadership, and innovation. Hear Nick share his compelling journey from humble beginnings as the child of Indian immigrants in Canada to hedge fund investor on Wall Street, and ultimately to turnaround CEO for multiple companies. Nick dives deep into the lessons learned from his upbringing, the immigrant work ethic, and how becoming a new parent has changed his perspective on life and business. Discover how Nick transitioned from Wall Street to running large organizations, why understanding the numbers is key for any business, and how using AI tools like ChatGPT is transforming productivity at IdeaScale. If you're a business owner, entrepreneur, or just passionate about innovation, you'll get actionable insights on eliminating waste, building metrics-driven teams, and using technology to scale. Nick also discusses IdeaScale's mission—to help organizations of any size harness the power of collaborative ideas—and shares how you can start innovating for free. Whether you're running a one-person shop or a global corporation, this episode is packed with practical wisdom to help you grow and future-proof your business. Connect with Nick on LinkedIn or try IdeaScale at ideascale.com. **Contact Ed Parcaut:** -

In this episode, we sit down with Nishit Jain, founder of Somersault and co-founder of Fruiters - two standout brands redefining fun and food in India. From building premium indoor play zones for kids to curating gourmet food experiences, Nishit shares his journey of entrepreneurship, innovation, and global business. With over a decade in international trade and leadership across Africa and India, he now focuses on delivering joyful, high-quality consumer experiences. Tune in for insights on brand building, supply chains, and creating businesses that truly delight their customers!Connect With Nishit - https://www.instagram.com/nish3k?igsh=MXkxbzBvZ2kwZW1kcA==https://www.instagram.com/somersault.in?igsh=MW03MDhhMzM0d3Jvag==https://www.instagram.com/fruiters_?igsh=azd2eW43MmY4cTJ2Podcast Related Emails - connect@pritika.coInstagram- https://www.instagram.com/pritika.looniaListen to the full podcast here - https://www.youtube.com/@PritikaLooniaOfficial Facebook - https://www.facebook.com/captainpritika/Learn From Me - www.pritika.co Listen to my podcast on - Jio saavn - https://www.jiosaavn.com/shows/sage-up-with-pritika-loonia/2/ZukCx7qhBVQ_ Spotify- https://open.spotify.com/show/7ErewAP263SgLXOUE8V0SI?si=f0c13ec52bb74062 Apple Podcast- https://podcasts.apple.com/in/podcast/sage-up-with-pritika-loonia/id1517629945

Madhavi Jain joins us today to talk about Connected Capital, getting better splits, more access to better deals, and her multifamily journey.----Continue the conversation with Brian on LinkedInJoin our multifamily investing community with like-minded apartment investors at the Tribe of TitansThis episode originally aired on June 27, 2025----Watch the episode on YouTube: https://www.youtube.com/channel/UCcsYmSLMxQCA9hgt_PciN3g?sub_confirmation=1 Listen to us on your favorite podcast app:Apple Podcasts: https://tinyurl.com/AppleDiaryPodcast Spotify: https://tinyurl.com/SpotDiaryPodcast Google Podcasts: https://tinyurl.com/GoogleDiaryPodcast Follow us on:Instagram: https://www.instagram.com/diary_of_an_apartment_investor Facebook: https://www.facebook.com/DiaryAptInv/ Twitter: https://twitter.com/Diary_Apt_Inv ----Your host, Brian Briscoe, has owned over twenty apartment complexes worth hundreds of millions of dollars and is dedicated to helping aspiring apartment investors learn how to do the same. He founded the Tribe of Titans as his platform to educate aspiring apartment investors and is continually creating new content for the subscribers and coaching clients.He is the founder of Streamline Capital based in Salt Lake City, Utah, and is probably working on closing another apartment complex in the greater SLC area. He retired as a Lieutenant Colonel in the United States Marine Corps in 2021 after 20 years of service.Connect with him on LinkedIn----Madhavi JainMadhavi is the President, Wealth strategist and a Podcast Host at Think Outside the Stocks, which is now recognized as Top 3% podcast globally.Madhavi helps her clients with a two-fold approach to Grow, Preserve, Protect and Pass generational wealth. An efficient savings vehicle with Infinite Banking and risk-managed investing in commercial real estate syndications. She is a passive investor coach and brings high quality investments to her clients via historically recession resistant asset classes such as multi family, self storage, industrial, senior assisted living, and more. Prior to her real estate exploration, Madhavi spent 16+ years in the IT industry mostly with one of the top 5 consulting firms and with her exit from the corporate world, she is now on a mission to “Change the financial trajectory of one family at a time and thousands more to go."Learn more about her at:https://www.linkedin.com/in/madhavinadejain/,https://thinkoutsidethestocks.com/, or  Podcast: https://rb.gy/kvrn4v

In this episode, host Shikha Jain, MD, speaks with Don Dizon, MD, about innovation throughout times of uncertainty in medicine, challenges currently facing physicians and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Dizon 1:44 •    The interview 2:27 •    How did you decide to become an oncologist and navigate a traditional academic career with many non-traditional “add-ons”? 3:01 •    Jain and Dizon on the importance of providing humanity to physicians. 7:19 •    Jain and Dizon on finding balance when providing patients with information.  9:03 •    Jain and Dizon on federal funding challenges facing oncology advancements.  10:17 •    Can you tell us more about transitioning to your new role at Tufts? 12:50 •    Jain and Dizon on the growing amount of career shifts in medicine. 17:22 •    How do we move forward with these new guardrails up from corporatization? 18:34 •    Jain and Dizon on how the age of social media has changed the perception, training and demands of doctors. 24:56 •    Dizon and Jain on the power of being able to admit “I don't know.” 28:22 •    What are some tips that you have for new attendings and people just starting in their careers? 33:54 •    Dizon and Jain on the importance of humanizing patients during their care. 38:34 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 44:17 •    How to contact Dizon 44:57 •    Thanks for listening 45:51 Don Dizon, MD, is a professor of medicine at Tufts University and is the system chief of hematology and oncology for Tufts Medicine. He is also the editor in chief of CA: A Cancer Journal for Clinicians, the flagship journal of the American Cancer Society as well as the vice-chair of membership and accrual at the SWOG Cancer Research Network. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dizon can be reached on Tiktok @drdonsdizon, Instagram @drdonsdizon and LinkedIn.  Disclosures: Jain and Dizon report no relevant financial disclosures. 

Surgical techniques in gynecology vary widely between surgeons, creating both excitement and frustration for residents trying to learn the "right way" to perform procedures. Howard and guest host Maddie White discuss this and more:• Trocar placement during laparoscopy requires careful consideration of patient factors and potential adhesions• Elevating the abdomen during trocar placement remains standard practice, though definitive evidence on its necessity would require studies of over 100,000 patients• Surgeons should understand power analysis to recognize when studies are underpowered to detect meaningful differences in rare complications• Visceral slide technique using ultrasound can identify adhesions and determine the safest entry point for laparoscopic surgery• Palmer's point may no longer be the safest entry point for many patients given the prevalence of bariatric surgeries• Jain's point (lateral to the umbilicus) may now be statistically safer for many patients with complex surgical histories• Vaginal cuff dehiscence rates are 6-10 times higher with laparoscopic/robotic hysterectomy compared to vaginal approaches• The higher dehiscence rate stems from using energy devices for colpotomy rather than cold scalpel techniques• Barbed sutures simplify cuff closure but don't reduce dehiscence rates compared to standard suturing techniques• Surgery consists of "a thousand little things done well" - mastering these micro-skills distinguishes excellent surgeons00:00:00 Surgical Techniques: Excited and Frustrated00:08:00 Elevation During Trocar Placement 00:17:00 Evidence and Power Analysis00:21:35 Visceral Slide Technique00:35:10 Alternative Trocar Entry Points00:40:10 Cuff Closure and Dehiscence Risk00:51:45 Laparoscopic vs Vaginal Colpotomies01:03:00 First Accredited OB-GYN Residency ProgramFollow us on Instagram @thinkingaboutobgyn.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This episode features a comprehensive discussion of research examining socially assisted robotics for children with autism. Madeline Jürgensen presents findings from two single-case design studies that investigated whether children with autism would attend to and learn from a small humanoid robot called Kebbi. The first study used a multiple baseline design to measure attending behaviors, revealing dramatic increases in eye contact and engagement when children worked with the robot versus human instructors. The second study employed an adaptive alternating treatment design to compare learning outcomes between robot and human instruction, finding that while children learned academic skills from both modalities, they showed preference for robot-delivered activities despite sometimes performing better with human instruction. The discussion includes important considerations about the novelty effect, social validity, and the future role of robotics in behavior analysis practice.  To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review. Show Notes References:   Berens, K. N. (2020). Blind spots: Why students fail and the science that can save them. Oakland, CA: The Collective Book Studio.  Darling, K. (2021). The new breed: What our history with animals reveals about our future with robots. Henry Holt and Company.  Shi, Z., Groechel, T. R., Jain, S., Chima, K., Rudovic, O., & Matarić, M. J. (2022). Toward personalized affect-aware socially assistive robot tutors for long-term interventions with children with autism. Journal of Human-Robot Interaction, 11(4), Article 39. https://doi.org/10.1145/3526111  Resources:   Association for Behavior Analysis International (ABAI): https://www.abainternational.org/  CentralReach Institute: https://centralreach.com/  University of Southern California Robotics and Autonomous Systems Center (RASC): https://rasc.usc.edu/research/    If you would like a copy of the articles discussed please reach out to madeline.jurgensen@centralreach.com

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/literary-studies

In this episode, we sit down with Poonam Jain — an Alchemist Coach, ICF-certified PCC, Energy Healer, and seasoned IT professional with over 22 years of global experience — to explore the powerful intersection of corporate life, entrepreneurship, mindset transformation, and energy work.

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/south-asian-studies

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion

Discover the fascinating journey of Sidharth Jain, founder of The Story Ink, India's leading book-to-screen adaptation company. From his early days as a stock trader to producing the acclaimed Netflix series "Trial by Fire," Jain shares insights on what makes stories screen-worthy, the challenges of adaptation, and how Indian content is evolving in the global streaming era. A must-read for aspiring filmmakers, authors, and anyone curious about the entertainment industry.00:34- About Sidharth JainSidharth is the founder of The Story Ink, which is India's leading book to screen adaptation company.He's also the founder of the House of Talkies, which is a Content Studio.

Disability inclusion in medical education needs critical, global dialogue. Here, Jain and Alwazzan highlight cultural differences, educator responsibility, and the power of local consultation to challenge ableism and advance justice. Read the accompanying article here: https://doi.org/10.1111/medu.15450

What if everything you know about Canadian immigration is only half the truth? In this explosive episode, I sit down with Sumit Jain, one of Canada's most trusted immigration professionals, to uncover the real game behind PR, study visas, work permits, and why most people fail—not because of paperwork, but because of bad advice. Whether you're planning to move, already in Canada, or stuck in limbo, this conversation will change how you think about immigration forever.

This week's episode of the podcast is in the MDM Mailbag format. I recruited Rishabh Jain, the CEO of eCommerce experience platform FERMÀT, to answer questions submitted by the MDM community. Among other topics, those questions related to:the "universal truths" of user acquisitiona viable "self-learning path" for acquiring data analytics / data science skillsthe role of technical media buyers going forwardthe purpose of the CMO rolewhat happens if Google is forced to divest part of its Network businessThanks to the sponsors of this week's episode of the Mobile Dev Memo podcast:INCRMNTAL⁠⁠. True attribution measures incrementality, always on.⁠⁠⁠Clarisights⁠⁠⁠. Marketing analytics that makes it easy to get answers, iterate fast, and show the impact of your work. Go to⁠⁠⁠ clarisights.com/demo⁠⁠⁠ to try it out for free.Interested in sponsoring the Mobile Dev Memo podcast? Contact ⁠Marketecture⁠.The Mobile Dev Memo podcast is available on:Apple PodcastsSpotify

This week on A Mental Health Break, we're taking a vital step towards understanding a challenging, yet often overlooked, aspect of mental health. We're honored to welcome Dr. Rakesh Jain, MD, MPH, a distinguished Clinical Professor of Psychiatry at Texas Tech University, and Sherland Peterson, who openly shares her personal journey of living with Tardive Dyskinesia (TD).More than 14 million Americans live with serious mental illness, often treated with antipsychotic medicines. But what happens when treatment leads to another debilitating condition? Dr. Jain will illuminate:What Tardive Dyskinesia (TD) is, its common signs and symptoms, and its profound connection to mental health.The critical findings from the IMPACT-TD study on challenges faced by patients and doctors.A revolutionary one-pill, once-daily treatment option that can integrate seamlessly with existing mental health plans.Sherland will bravely share:Her personal story of living with TD, offering invaluable firsthand insight.The impact TD has had on her daily activities, mental health, and social life.This episode is a crucial conversation for anyone seeking to understand the complexities of mental health treatment, the importance of holistic care, and the power of resilience. Join us for a break that truly educates and empowers.Support the showHave a question for the host or guest? Want their freebee? Are you looking to become a guest or show partner? Email Danica at PodcastsByLanci@gmail.com.This show is brought to you by the Empathy Set and Coming Alive Podcast Production.CRISIS LINE: DIAL 988

Technical brilliance is table stakes. Influence is the multiplier. In this episode, Hakeem Adebiyi sits down with Francie Jain—CEO of Terawatt, the coach-matching platform—to unpack:Google's Project Aristotle: why psychological safety outperforms raw IQA Colorado hospital that saved $32 M per year by embracing group coaching“Opposite-Strengths” teaming: pairing your weakness with someone's superpowerThree quick wins STEM pros can start today to boost executive presenceHow Terawatt lets companies RFP a coach the way you'd book a room on AirbnbHit ▶, then follow the show so you never miss an episode packed with actionable leadership science.

In this Episode of World Footy Team Troy, Greg, and Adam are joined by Jarrod Landells and Dave Jain. The team podcast will provide you with an update and discuss the latest results and news from around the world.

In this episode, recorded live at the 2025 ASCO annual meeting, host Shikha Jain, MD, speaks with Sonali Smith, MD, about the power of mentorship and advocacy, preserving the academic mission of research within health care systems and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Smith 1:56 •    The interview 3:14 •    What was your journey to get to where you are now in your career?  3:38 •    How do you incorporate your advocacy work into patient care, and how do you advise other physicians on their advocacy journeys? 12:09 •    Jain and Smith on how the politicization of health care has resulted in the rise of and demand for public physician advocacy.  13:32 •    Jain and Smith on the impacts of today's climate on clinical research work.  18:24 •    Can you speak about your ELAM capstone project discussing how to preserve academics? 25:11 •    Are there any lymphoma studies presented at ASCO this year that have excited you or interested/educated you? 31:54 •    Jain and Smith on how ASCO underlines the importance of international collaboration in oncology research. 36:46 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 39:47 •    How to contact Smith 40:27 •    Thanks for listening 41:03 Sonali M. Smith, MD, is the Elwood V. Jensen professor of medicine, section chief of hematology/oncology, co-leader of the cancer service line, and co-director of the lymphoma program at the University of Chicago in the department of medicine. She is a clinical investigator in lymphoma and a clinical expert in Hodgkin and non-Hodgkin lymphomas. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Smith can be reached on LinkedIn or via email smsmith@bsd.uchicago.edu.  Disclosures: Jain and Smith report no relevant financial disclosures. 

The Harvest Series Podcast returns with a new season!In this episode, Rose Claverie interviews Satish Kumar, a former Jain monk, peace activist, and advocate for simple living. Satish shares the profound lessons he's learned about courage, love, and the importance of embracing the unknown. His personal journey, which includes walking from India to the world's nuclear capitals without money, highlights the human connection that unites us all, regardless of nationality or religion.In an era where conflict seems pervasive, Satish's message is clear: love is the answer to every problem. He talks about the courage required to live authentically, how love can bridge divides, and why peace must start in our hearts. This episode is filled with invaluable insights on how to live a life rooted in courage, simplicity, and compassion. If you want to know more about the Satish Kumar foundation.Chapters 00:00 - Introduction to Satish Kumar 00:30 - The Meaning of Courage 01:00 - Escaping the Monastery: A Moment of Courage 03:00 - The Journey to Find Peace 06:00 - The Importance of Love in Conflict Resolution 09:00 - Walking for Peace: 2.5 Years, 15 Countries 14:00 - Satish's Encounter with Bertrand Russell 18:00 - Bhutan: A Country of Happiness 22:00 - Courage in Relationships: Satish's 40-Year Marriage 25:00 - The Bravest People Satish Has Met 28:00 - Conclusion: A Life of Action, Not AchievementYou can follow us on Instagram at @HarvestSeries or @rose.claverie for updates.Watch our podcast episodes and speaker sessions on YouTube: Harvest Series.Credits:Sound editing by: @lesbellesfrequencesTechnicians in Kaplankaya: Joel Moriasi & teamMusic by: ChambordHarvest Series is produced in partnership with Athena Advisers and Capital PartnersHarvest Series Founders: Burak Öymen and Roman Carel

"A Sankhya Yogi loses ego every day. A Scholar gains ego every day.” In this episode, I chat with Ram Jain — a fifth-generation yogi and founder of Arhanta Yoga, with ashrams in both India and the Netherlands. Ram's journey began at a Vedic school at age 8, and his life has since been dedicated to teaching yoga as a path to self-realization and empowerment.We talk about his evolution from aspiring dancer to spiritual teacher, how yoga is perceived differently across cultures, and the deeper meaning behind practices like Sankhya and Gyan Yoga. Ram has a beautiful way of flipping questions back on me, sparking some deep reflection on identity, ego, and the dance between individuality and oneness.He also shares practical advice on choosing a yoga teacher training, including the value of hands-on teaching and staying rooted in tradition.Takeaways from our conversation:➖ Yoga is ultimately about coming home to yourself.➖ Our background shapes how we understand and experience yoga.➖ Some Western students find ideas like karma and reincarnation a bit unfamiliar at first.➖ Sankhya Yoga brings a logical lens to deep questions about who we are.➖ Life unfolds in its own perfect timing — things come when we're ready.➖ Each soul is unique, yet part of something greater.➖ Yoga invites us to explore who we are beneath all the labels.➖ A strong yoga teacher training should include real-world teaching practice.➖ Experiencing yoga in its cultural roots can bring deeper insight and connection.Find Ram:

This episode recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable features Dr. Sachin Jain, President and Chief Executive Officer, SCAN Group. Dr. Jain discusses how SCAN is redefining member experience through human-centered care and highlights the urgent need for deeper payer-provider partnerships to drive true innovation and better outcomes in healthcare.

In this episode, host Shikha Jain, MD, speaks with Sadie Dobrozsi, MD, about the power of information in personalized oncology care, understanding the impacts of genetic testing and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Dobrozsi 1:39 •    The interview 2:03 •    What was your path to this field of pediatric oncology, and how did you decide to focus on genetic testing?  2:33 •    Can you talk about what it means to use genomics to optimize therapy and tailor precision medicine, and how you implement that in your work? 7:58 •    Why is it so important to continue focusing on funding precision medicine as an advancement in cancer care? 10:34 •    Can you talk about your work with BRCA research and how treatment and surgeries have evolved with our understanding of it?  14:30 •    Jain and Dobrozsi on the importance of shared decision-making in oncology, and how genomics plays a role in that ongoing conversation. 20:18 •    How do we navigate difficult conversations with increasingly younger patient populations, and why are we having these conversations more now than ever before? 23:55 •    When it comes to genetic testing, how much knowledge is “good knowledge”? 27:05 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 34:31 •    How to contact Dobrozsi 35:12 •    Thanks for listening 35:39 Sadie Dobrozsi, MD, is a board-certified pediatric oncologist, a nationally recognized leader in complex care delivery, and the medical director of genetic testing and oncology imaging at Evolent, a leading specialty and primary care management company.  We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dobrozsi can be reached on LinkedIn or via email sdobrozsi@evolent.com. Disclosures: Jain and Dobrozsi report no relevant financial disclosures. 

Do cell phones cause brain cancer?  Does using an antiperspirant increase the risk of breast cancer? Does fluoride in the water increase the risk of bone cancer? Is the HPV vaccine lifesaving or dangerous?  In this episode, I am joined by Dr. Shikha Jain, an academic hematologist and oncologist. We start by busting cancer myths and then move on to discuss the impact of the “Make America Healthy Again Movement” (MAHA)on cancer care and cancer research, and why the rationale behind the MAHA movement is FLAWED and DANGEROUS.  Which of the following is associated with getting cancer or spreading cancer Biopsies Specific viruses Consuming sugar  Mammograms Living near a Power line Cell phones  Deodorant and antiperspirants  Microplastics  Microwaving  If surgery to remove a cancerous growth spreads the cancer? Estrogen- birth control pills, local estrogen, systemic estrogen The impact of current political policies on cancer treatment and research Obesity Processed food HPV vaccine Fluoride in the water The financial incentive behind the MAHA movement Why placebo-controlled trials are not always used in research, and would be dangerous Defunding of NIH Cancer Research, including labs and clinical trials The US Brain Drain  Over 9.5 billion dollars, representing over 2000 NIH grants, have been terminated.  In the links below, expand the abstract column to see the details of the research.      List of NIH grants that have been defunded      https://airtable.com/appjhyo9NTvJLocRy/shrNto1NNp9eJlgpA?        Ffj6Q%3Aview=plasNjSudszRmPvEo&Ffj6Q=allRecords      List of NIH Cancer Research that Has Been Defunded     https://airtable.com/appjhyo9NTvJLocRy/shrNto1NNp9eJlgpA?Ffj6Q=sfsqqf7AYxKbZi37s&Ffj6Q%3Aview=plasNjSudszRmPvEo Dr. Shikha Jain, MD, FACP, is a board-certified oncologist, national health media contributor, and founder of Women in Medicine®. She's a tenured associate professor at the University of Illinois and was named Illinois Physician Leader of the Year, one of Modern Healthcare's Top 25 Emerging Leaders, and a Medscape Rising Star in Medicine. Through her clinical work, national advocacy, and powerful storytelling, Dr. Jain is transforming how we think about medicine, leadership, and the future of healthcare. https://www.wimedicine.org/ https://www.wimedicine.org/wim-summit https://shikhajainmd.com/                                How to Know an Expert is an Expert Episode 157: How to Find a Clinician that's Not Clueless Substack Posts A Guide to Finding a Menopause Clinician That's Not Clueless Let's Play…Is Your Doctor Really a Menopause Expert? Dr. Streicher is on SUBSTACK      DrStreicher.Substack.com Articles Monthly newsletter All COME AGAIN podcast episodes Monthly News Flash Reports on recent research  Monthly Zoom Ask Me Anything Webinar Information on Dr. Streicher's COME AGAIN Podcast- Sexuality and Orgasm   Lauren Streicher MD, is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause, and a Senior Research Fellow of The Kinsey Institute, Indiana University. She is a certified menopause practitioner of The Menopause Society. She is the Medical Director of Community Education and Outreach for Midi Health.   Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine.    LINKS Subscribe To Dr. Streicher's Substack Information About the COME AGAIN Podcast Dr. Streicher's CV and additional bio information To Find a Menopause Clinician and Other Resources  Glossary Of Medical Terminology Books by Lauren Streicher, MD  Slip Sliding Away: Turning Back the Clock on Your Vagina-A gynecologist's guide to eliminating post-menopause dryness and pain Hot Flash Hell: A Gynecologist's Guide to Turning Down the Heat Sex Rx- Hormones, Health, and Your Best Sex Ever The Essential Guide to Hysterectomy                                      Dr. Streicher's Inside Information podcast is for education and information and is not intended to replace medical advice from your personal healthcare clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast.               

This episode recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable features Dr. Sachin Jain, President and Chief Executive Officer, SCAN Group. Dr. Jain discusses how SCAN is redefining member experience through human-centered care and highlights the urgent need for deeper payer-provider partnerships to drive true innovation and better outcomes in healthcare.

On this episode of The Wholesome Fertility Podcast, I am joined by Dr. Nirali Jain (eggspert_md), a board-certified OB/GYN and reproductive endocrinologist at Reproductive Medical Associates (RMA). Dr. Jain shares her expert insights on fertility preservation for individuals undergoing cancer treatment, a crucial yet often overlooked aspect of reproductive care. We explore what options are available for fertility preservation, including egg and sperm freezing, and why it's so important to initiate these discussions before starting chemotherapy or radiation. Dr. Jain also explains the difference between Letrozole and Clomid, the impact of estrogen-sensitive cancers on IVF treatments, and innovative approaches like random-start cycles and DuoStim protocols. Whether you're facing a cancer diagnosis or simply thinking proactively about your reproductive future, this conversation is filled with knowledge and reassurance. Key Takeaways: Why it's essential to discuss fertility before starting cancer treatment. The role of Letrozole in estrogen-sensitive cancers and fertility preservation. Differences between Letrozole and Clomid, and why Letrozole is often preferred. How new protocols like DuoStim and random-start cycles are improving outcomes. Why fertility preservation is important even for those without a cancer diagnosis. Guest Bio: Dr. Nirali Jain (@eggspert_md) is a board-certified OB/GYN and fertility specialist at Reproductive Medicine Associates (RMA) in Basking Ridge, New Jersey. She earned both her undergraduate degree in neurobiology (with a minor in dance!) and her medical degree from Northwestern University, before completing her residency at Weill Cornell/NYP, where she served as co-Chief Resident, and her fellowship in reproductive endocrinology and infertility at NYU Langone. Deeply passionate about women's health and fertility preservation, Dr. Jain blends the latest research and cutting-edge treatments with compassionate, patient-centered care. Her interests include third-party reproduction and oncofertility, and she is especially passionate about supporting patients navigating fertility preservation through a cancer diagnosis. Outside of the clinic, Dr. Jain is a trained dancer, a dedicated global traveler, and an adventurer working toward hiking all seven continents with her husband. Her diverse experiences, from international medical rotations to personal connections with friends and family navigating infertility, have shaped her into a warm, resourceful, and determined advocate for her patients. Links and Resources: Visit RMA websiteFollow Dr. Nirali Jain on Instagram For more information about Michelle, visit www.michelleoravitz.com To learn more about ancient wisdom and fertility, you can get Michelle's book at: https://www.michelleoravitz.com/thewayoffertility The Wholesome Fertility facebook group is where you can find free resources and support: https://www.facebook.com/groups/2149554308396504/ Instagram: @thewholesomelotusfertility Facebook: https://www.facebook.com/thewholesomelotus/ Disclaimer: The information shared on this podcast is for educational and informational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health or fertility care. --  Transcript:   # TWF-Jain-Nirali (Video) ​[00:00:00]  **Michelle Oravitz:** Welcome to the podcast Jain.  **Dr. Nirali Jain:** Thanks so much for having me **Michelle Oravitz:** Yeah, so. **Michelle Oravitz:** I'm very excited to talk about this topic, which, um, actually you don't really hear a lot of people talking about, which is how to preserve your fertility if you're going through a cancer diagnosis and if you have to go through treatments. 'cause obviously that can impact a lot on fertility. **Michelle Oravitz:** I have, um, seen actually like a colleague of mine go through. And she also preserved her fertility and, and now she has a baby boy. so it's really nice. **Michelle Oravitz:** to **riverside_nirali_jain_raw-video-cfr_michelle_oravitz's _0181:** so nice. **Michelle Oravitz:** So I'd love for you first to introduce yourself and kind Of give us a background on how you got into this work. **Dr. Nirali Jain:** Of course. Um, so I am Dr. Narly Jane. I am, um, an OB GYN by training, and then I did an additional, after completing four years of residency in OB GYN and getting board certified in that, I did an additional training in reproductive endocrinology and [00:01:00] infertility or otherwise known as REI. So now I'm a fertility specialist. **Dr. Nirali Jain:** Um, I trained at Northwestern in Chicago, so I went to undergrad and medical school there. And then, um, home has always been New Jersey for me, so I moved back out east to New Jersey. Um, I did all my training actually in New York City at Cornell for residency and NYU for fellowship. Um, and then moved to the suburbs. **Dr. Nirali Jain:** Um, and now I'm a fertility specialist in, in Basking Ridge at Reproductive Medical Associates.  **Michelle Oravitz:** Very impressive background. That's awesome.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** I'd love to hear just really. About what your process is. If a person has been diagnosed with cancer, like what is the process? What are some of the things that you address if they are trying to preserve fertility, and what are some of the concerns going  **Dr. Nirali Jain:** yeah, yeah. All great questions. So, you know, there's a lot of us, uh, the Reis. Are a very small, [00:02:00] there's a very small number of us. So in terms of specializing in fertility preservation, technically we all are certified to treat patients with cancer and kind of move them through fertility preservation before starting chemotherapy. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, luckily we've been working closely with oncologists in the past several years just to establish some type of streamlined system because having a diagnosis of cancer and hearing all that information. Especially when you're young is so hard. So I think that's, that's where my interest started in terms of being able to speak to and counsel cancer patients. **Dr. Nirali Jain:** I think it is a very specific niche that you really have to be comfortable with in our field. Um, I. So I'll kind of walk you through, you know, what it, what does it look like, right? Um, you go into your oncologist's office suspecting that you have this, this lump. I'll take breast cancer, for example. It could really be any kind of cancer. **Dr. Nirali Jain:** Um, but breast cancer in a reproductive age patient or someone that's in those years where you're starting [00:03:00] to think about building a family, planning a family, um, or if you have kids at home, that's usually the type of patient that we see come in with a breast cancer diagnosis. So. Kinda just taking that, for example, um, the minute that you're diagnosed, it's really your oncologist's responsibility to counsel you on what treatment options are going to be offered to you. **Dr. Nirali Jain:** And then based off of the treatment options, it's important to know how that affects your reproduction. So how does it affect your ovaries in the short term, in the long term, um, in any way possible. So. Once a patient is initially referred from their oncologist to myself or any other fertility specialist, they come into my office and we just have a 30 minute conversation really talking about family planning goals. **Dr. Nirali Jain:** Any kids that they've had in the past either naturally conceived or through um, IVF, and then we talk about where they're at in their relationship. Are they married, are they not? Are they with a partner, [00:04:00] a male partner, a female partner, whatever it might be. It's important to know the social standpoint, um, especially in this sensitive phase of life. **Dr. Nirali Jain:** So patient patients usually spend anywhere from 30 minutes to an hour. Um, just kind of talking through where they're at, how they're feeling, what their ultimate childbearing goals are. And then from there we do an ultrasound and that's when I'm really able to see, you know, the, the reproductive status. **Dr. Nirali Jain:** So what do the ovaries look like? What does the uterus look like? Is there something that I need to be concerned about from a baseline GYN standpoint? Um, and all of those conversations are happening in real time. So. I think one of the things is patients come in and they're like, I'm already so overwhelmed with all this information from my oncologist, and now my fertility specialist is throwing all this information at me. **Dr. Nirali Jain:** Luckily, the way I like to frame it is you come in and you just let go. Like you let us do the work because in the background we're the ones talking to your oncologist. We're the [00:05:00] ones giving that feedback and creating a timeline with your oncologist. Um, and really I think just getting in the door is the hardest part. **Dr. Nirali Jain:** So once patients are here to see us, we go through the whole workup. We do anything that we would do for a normal patient that came in for fertility preservation. And then based off of where they're at in their journey, we talk about what makes sense for them, whether that means freezing embryos, freezing eggs, they're very similar in terms of the, the few weeks leading up to the egg retrievals. **Dr. Nirali Jain:** So I have that whole conversation just at the initial visit. And then from there we talk about the timeline behind the scenes and make sure that it works with their lives before moving forward. **Michelle Oravitz:** So for people listening to this, why, and this might be an obvious question, but to some it might not be,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** why would somebody want to preserve. eggs or sperm. 'cause I've had actually some couples  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** come to me where the husband preserved the sperm and they had to go through IVF just because he was going [00:06:00] through cancer treatments. So he had to preserve the sperm ahead of time.  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** people need to consider doing that before doing cancer treatments?  **Dr. Nirali Jain:** So there are certain cancer treatments that do affect the ovaries and the sperm health, and you know, for men and women, it affects your reproductive organs. In a similar way, um, depending on the type of chemotherapeutic agent, there are some that are more dangerous in terms of, um, being toxic to your ovaries or toxic to your sperm. **Dr. Nirali Jain:** And those are the instances where we are really thinking about what's the long-term impact because there's medications that oncologists do give patients, and our oncologists are amazing, the ones that we work with, Memorial Sloan Kettering from Reproductive Medical Associates through RMA, um, and. **Dr. Nirali Jain:** They're just so good at what they do and are so well-trained, so they know in the back of their mind, is this going to impact your ovaries or your sperm health or not? Um, and I [00:07:00] think that any chemotherapy, you know, your ovaries are these, these small organs that are constantly turning over follicles every month. **Dr. Nirali Jain:** So every month we're losing those eggs, and if they don't become. If an egg isn't ovulated, it doesn't become a baby, it's just gonna die off. So I counsel even patients that don't have cancer, I counsel them on fertility preservation as young as possible. You know, between the ages of 28 and 35, that's like the best time to preserve your fertility. **Dr. Nirali Jain:** So in cancer patients, there's an extra level added to that where even if they are a little bit younger, a little bit older. Your eggs are not gonna be the same quality. There's gonna be higher level of chromosomal errors, more DNA breakage, um, and, and bigger issues that lead to issues with conceiving naturally afterwards. **Dr. Nirali Jain:** So I think that it's important to consider how that chemotherapy is going to affect them or how surgery would affect them if it was, for example, a GYN cancer where [00:08:00] we're removing a whole ovary, you know, what, what do we have to do to preserve your fertility in that case? And those are important conversations to have. **Michelle Oravitz:** Yeah. for sure. I know that a lot of people are also concerned, you know, with going through the IVF process, you're taking in a lot of estrogen, a lot of hormones, and many cancers are actually estrogen sensitive. So I wanted to talk to you about that. 'cause I know that the data shows that it's. It's been fine, which some people might find surprising, but I wanted you to address that and just kind of **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** from your perspective.  **Dr. Nirali Jain:** That's so interesting that you asked that question because I actually, my whole I I graduated fellowship last year and my entire, like passion project in fellowship was looking at one of the drugs that we use to suppress the estrogen levels specifically in cancer patients. Um, and I had presented this at a few of our reproductive meetings. **Dr. Nirali Jain:** Um, A SRM is one of our annual meetings where all of the reiss get together. A lot of male fertility [00:09:00] specialists come and we kinda just talk about. Specific things and fertility preservation for cancer patients is, has been an ongoing topic of interest for all of us. Um, and it's important to know that there are different medications that we can offer. **Dr. Nirali Jain:** Letrozole is the one that I, um, have a particular love for and I, uh, you know, I use all the time for my patients, um, for different reasons, but it suppresses the exposure that your body has to estrogen. And there's mixed data, um, out there in terms of, you know, does Letrozole suppression actually impact, you know, does it help or. **Dr. Nirali Jain:** Or does it have no impact on your future risk of cancer after treatment? Um, and that honestly is still up for debate. But what we do know is that there's no increased risk of cancer recurrence in patients that have undergone fertility preservation with or without Letrozole. Um, Letrozole is one of those things that we can give, and the way it works is basically. **Dr. Nirali Jain:** It masks that [00:10:00] conversion. It, it doesn't allow for conversion from those androgens in the male hormones over to estrogen. Um, and so your body doesn't really see that estrogen exposure. It stays nice and low throughout your cycle, and it does help with actually ovarian maturation and getting mature eggs harvested and, um, helps a little bit with, with quality too. **Dr. Nirali Jain:** So I think that it's really nice in terms of having that available to us, but know that. It's not, it's not essential that you have it, really, the data showing plus minus. Um, but there are certain things that we can do to protect the ovaries, protect your exposure to estrogen. Um, and so that shouldn't be top of mind of concern when we're going through fertility preservation, even with an estrogen sensitive cancer. **Michelle Oravitz:** Actually, so, uh, on a different topic, kind of going back to that, so Letrozole versus Clomid, I, it's like a, the questions I personally feel just based on what I've heard and like my own research that Letrozole would be kind of like the more. [00:11:00] Um, the, it's, it's a little better, but I know that it really depends on the person as well.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** they might do better with Clom, but I'd love to hear your perspective and kind of pick your brain on this.  **Dr. Nirali Jain:** totally. You're choosing all the, all the right questions because these are all of my, my specific interests and niches. So  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** Letrozole is basically, you know, we use Letrozole and Clomid in. Patients that don't have cancer and patients that come in for an intrauterine insemination, that's kind of the most common scenario where we're thinking about, you know, which medication is better? **Dr. Nirali Jain:** Letrozole or Clomid and Clomid used to be the, the most common medication that we use, we dose patients, you know, have 50 milligrams of Clomid, give them five days of the medication. It's an oral pill. Feels really easy and. The way it works is really, it recruits more than one follicle, so it really helps with the release of, um, more than one follicle growing more than one follicle in the ovary. **Dr. Nirali Jain:** Um, but it has a little bit [00:12:00] higher of a risk of twins because that's exactly what it's good at. Um, Clomid, not so much in the cancer. In the cancer front, it's not really used there because it's considered, from a scientific perspective, it's considered like a selective estrogen receptor modulator. So it doesn't necessarily suppress your estrogen levels in the same way that Letrozole does versus. **Dr. Nirali Jain:** Letrozole is an aromatase inhibitor, so it really blocks the chemical conversion of one drug or one hormone to the other hormone. Um, the reason we love Letrozole so much, and I don't mean to like gush over Letrozole, but um, it's a mono follicular agent, so it works really well at recruiting one follicle  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** you know, every OB-GYN's nightmare in a way is having multiples when you didn't intend on having multiples at all. **Michelle Oravitz:** so  **Dr. Nirali Jain:** Um. **Michelle Oravitz:** were saying that, um, there's more of a chance of twins, it's Clomid, not letrozole.  **Dr. Nirali Jain:** Yes, there's a higher chance with Clomid versus Letrozole. And I mean, don't get me wrong, there's a chance of twins with [00:13:00] any type of assisted reproductive technology. Even when we're doing single embryo transfers, there's a chance that it's gonna split. So, um, the chance is always there just like it is in the natural world. **Dr. Nirali Jain:** But we know for a fact that. CLO is really good at recruiting many follicles. It's good for certain patients that don't respond well to Letrozole. Um, but Letrozole is kind of our, our go-to drug these days just because of all the benefits that we've seen.  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** These are all fun things to ask because I, I love talking to our eis 'cause there's so much information that I'm always  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** learn a lot from my patients in my own research, but it's really cool. Picking your guys' brains. So another question I have, and I have actually talked to Dr. Andrea Elli, he's been on,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** and he does a lot of endometriosis and, and immune related work as well,  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** so. I'd love to know just from your perspective. One thing that I do know from, based on what I've heard is that the, [00:14:00] guess like you were just saying, that breast cancer or estrogen sensitive breast cancer doesn't seem to be affected by IVF cycles, however, and endometriosis lesions do get affected.  **Dr. Nirali Jain:** Yeah. **Dr. Nirali Jain:** that's a great question. So, you know, every, there are so many complex G mind diagnoses that the, that our patients come in with. Um, and endometriosis is a big one because there is clear data that endometriosis is linked to infertility. So we think about, you know, when a patient comes in with endometriosis, we really do think about the different treatment options and what are the short-term and long-term impacts of the hormones that we're giving 'em. **Dr. Nirali Jain:** Um, these days, again, kind of going back to Letrozole, we, letrozole is something that I give all of my endometriosis patients because it helps suppress their estrogen because we know.  **Michelle Oravitz:** interesting.  **Dr. Nirali Jain:** is very responsive to estrogen and leads to this dysfunctional regulation of all the endometrial tissue that can really flare in a, [00:15:00] in a cycle, or shortly after a cycle. **Dr. Nirali Jain:** I. So we really, for endometriosis patients, the, the best treatment is being on birth control because we don't see that hormonal fluctuation. The up and down of the estrogen and the progesterone, that's what leads to those flares. Um, so I really, I watch patients closely after their cycles too, because you definitely can have an endometriosis flare and we say the best treatment for endometriosis is pregnancy, right? **Dr. Nirali Jain:** That's when you're suppressed, that's when you're at your lowest. Um, and patients, my endo patients feel so good in pregnancy because they have. Hormones that are nice in that baseline, they're not getting periods of course. Um, and that's truly, truly the best treatment.  **Michelle Oravitz:** That's interesting.  **Dr. Nirali Jain:** But it is important to consider when you're going through infertility treatments. **Dr. Nirali Jain:** How does my endometriosis affect the short and long-term effects of the fertility medications? And really not to, not to say that they're bad in any way. I think a lot of endometriosis patients go through IVF and have success and do really, really well, and that's kind of the push that they need. [00:16:00] Um, but it's important to be mindful of the bigger picture here. **Dr. Nirali Jain:** It's not just, you're not just a number of. A patient with endo coming in, getting the same protocol. It's really individualized to the extent of your lesions, what symptoms you're having, what grade of endometriosis, where your lesions are. So we're the RAs are thinking about everything before we actually start your protocol. **Michelle Oravitz:** It's crazy how in depth it is, and it's, it, there's just so, it's so multifaceted,  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** when it's females  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** are a little, I mean, they can, you know, there, there's definitely a number of things, but it's not as complicated and interconnected  **Dr. Nirali Jain:** Exactly. Exactly. That's so true. **Michelle Oravitz:** And so one question I actually have, this is kind of really off topic, but something that I was curious about. **Michelle Oravitz:** 'cause I heard about a while  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** a, a type of cancer treatment that was used. I'm not sure exactly what it was, but for some reason it actually caused follicles to grow, [00:17:00] or to multiply. And they were **Dr. Nirali Jain:** Interesting. **Michelle Oravitz:** this definitely. Puts, um, the whole idea of like a woman being born with all the follicles she'll ever have on its head, I thought that was really Interesting. **Michelle Oravitz:** Now I learned a little bit about it. I don't think it really went further than that,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** one of those things that they're like, Hmm, this is interesting. I don't know, it was kind of a random side effect of this chemo drug. I dunno if it was a chemo drug or a cancer drug.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** ever heard of that. **Michelle Oravitz:** So I was just **Dr. Nirali Jain:** I haven't, I mean, that's interesting. I feel like I'd have to look into that because that would be definitely a point of interest for a lot of Reis. But it kind of does go back to the point of, you know, women are really born with all the eggs we're ever gonna have. So it's about a million, and then it just goes down from there. **Dr. Nirali Jain:** And the, by the time you start having periods, I like to kind of show my patients a chart, but you have a couple hundred thousand eggs and you ovulate one egg a month. That's, you know. Able to [00:18:00] progress into a fertilized egg and then into a, an embryo into a baby, um, if that's your goal. But otherwise, patients that are having periods and not trying to actually get pregnant, we're losing hundreds of eggs a month. **Dr. Nirali Jain:** So.  **Michelle Oravitz:** Mm.  **Dr. Nirali Jain:** It's important to kind of think about that decline, and it's important to know that that rate can be faster in patients with cancer, patients with low ovarian reserve. And sometimes when you have the two compounded, that's when a fertility specialist is definitely, you know, in the queue to, to have a discussion with you in terms of what that means and how you can reach your family building goals despite being faced with that, with that challenge. **Michelle Oravitz:** Yeah. **Michelle Oravitz:** I mean, 'cause we know oxidative stress is one of the things that can cause, uh,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** quality eggs, but it's also can cause cancer. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** um, similar, you know, like things that really deplete the body could definitely impact. Um, and then what are your thoughts? I know I'm asking you all kinds of random questions, **Dr. Nirali Jain:** I love it. **Michelle Oravitz:** are your thoughts about doing low simulation in certain [00:19:00] circumstances versus high stem? **Michelle Oravitz:** Sometimes people don't respond as well to higher stems.  **Dr. Nirali Jain:** Yeah, that's a great point. I think that it kind of all goes back to creating an individualized protocol. If. A patient's going to a practice and basically just getting a protocol saying, this is our standard. We start with our standard of, you know, I, I think about the standard, which is 300 of the FSH or that pen that you dial up, and then 150 units of that powder vial. **Dr. Nirali Jain:** And we have patients mixing powders all the time, and that's kind of our blanket protocol that we give patients. But that's not really what's happening behind the scenes. And if you're given a protocol that's, and being told, you know, this is kind of what we give to everyone, it's probably not the right fit for you. **Michelle Oravitz:** Yeah, I  **Dr. Nirali Jain:** Um, there are certain patients that respond to a much lower dose and do really, really well, and then some patients that need a much higher dose. Um, and I think it's, that's kind of like the fun part of being an REI of being able to individualize the [00:20:00] protocol to the patient. Um, and I know for a fact there are so many, luckily, you know, we have so many leaders in REI that have been. **Dr. Nirali Jain:** Have dedicated their entire careers to researching these different protocols and how they can help different patients. Um, patients with lower a MH, you know, might benefit from a duo stim protocol, for example. That's kind of the first one that comes to mind, but a protocol where we're using those follicles from the second half of a cycle. **Dr. Nirali Jain:** I would've never thought that those were the follicles that  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** would be better than the first half of the cycle,  **Michelle Oravitz:** Wait,  **Dr. Nirali Jain:** but, **Michelle Oravitz:** that. Explain that. Um, because I think that that's kind of a unique  **Dr. Nirali Jain:** mm-hmm.  **Michelle Oravitz:** that I haven't heard of.  **Dr. Nirali Jain:** Yeah, so there's this new day. It's still kind of developing, but um, kind of going back to, you know, what's an individualized protocol? Duo STEM is one of the newer protocols that we've started using. I, I've used it once or twice in patients. Um, but it goes back to the research that shows that you might actually have two different periods of time in a menstrual cycle where you could potentially recruit [00:21:00] follicles. **Dr. Nirali Jain:** You could have a follicular phase where there's a certain cohort of follicles recruited, and then you have a follicle that forms creates a corpus glut.  **Michelle Oravitz:** um, protocols  **Dr. Nirali Jain:** Yep. And then you basically go through the follicular protocol and then a few days after a retrieval, instead of waiting for a new follicular cohort or follicular recruitment from the first half of your menstrual cycle, you actually use the luteal phase and you recruit those follicles that would've actually died off or have been prematurely recruited in a prior cycle. **Dr. Nirali Jain:** So **Michelle Oravitz:** that's So  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** you just do a similar, I guess, um, medicine,  **Dr. Nirali Jain:** go right back into it.  **Michelle Oravitz:** do the same exact thing, but right after ovulation.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** Fascinating. That's really interesting.  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** has been your experience with that?  **Dr. Nirali Jain:** I think it's, honestly, it's mixed. Um, so far, you know, our data from fertility and sterility and A SRM, it, it shows support for these DUO STEM [00:22:00] protocols, saying that if patients don't have that great quality of eggs or if they have a very low number, maybe they'd benefit from starting the meds earlier and recruiting follicles. **Dr. Nirali Jain:** A little bit earlier. Um, so we've seen positive results so far. A lot of work to be done in terms of really understanding it. Um, and of course, as a new attending, I have a lot more experience to kind of build on. Um, but I, I have seen success from it. **Michelle Oravitz:** That's fascinating. Are there any other new technologies, like new add-ons, um, that you've seen, that you've found to be really cool or interesting?  **Dr. Nirali Jain:** I think the biggest thing, actually, kind of going back to our whole topic for today is fertility preservation cancer patients. One of the biggest things that I've learned recently is that we used to start fertility, um, patients. You know, only in the beginning of the cycle days, two or three is technically like when most. **Dr. Nirali Jain:** Most clinics, um, start patients, but for our cancer patients, sometimes you don't have that time. You don't wanna wait a full month to [00:23:00] restart, um, your, you know, your menstrual cycle and then do the fertility preservation and then delay chemotherapy a full month. So we started doing what we call random starts. **Dr. Nirali Jain:** So you basically start a patient whenever they come in. You know, it could be the day after your consultation, the day of your consultation. I've kind of seen all of the above. Um, and we've seen really good success with random starts, per se. Um, and we've been doing a lot more of that, where it's not as dependent on where you're at in your cycle. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, obviously there's a difference in outcomes. You might not be a great candidate for it, so definitely it's worth talking to your doctor about it. But it kind of gives relief to our cancer patients where if you have a new cancer diagnosis and you're like, oh, I just finished my period, like, I can't even start a cycle until next month. **Dr. Nirali Jain:** That's not always true. Um, so it's always worth it to go into see a fertility specialist and just get, you know, get the data that you need right away, and then you can make a decision later on. **Michelle Oravitz:** For sure. Um, Yeah. **Michelle Oravitz:** and I wanted to kind of cover a lot of different topics 'cause I know that [00:24:00] some people are gonna wanna hear what you have to say that don't necessarily, or, uh, have cancer. But it is important. I, I think that, you know, if you get to thirties and you haven't gotten married or you don't have a partner, I think it's really important to preserve your fertility in general.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** important thing. And then if you were going through a cancer diagnosis and you decided to preserve your fertility, um, guess more for women because they're eventually going to be thinking about transfers after they go through treatment. So what are some of the things that they would need to consider as far as that goes? **Michelle Oravitz:** Like after the  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** then they go through the cancer treatments. Um, and then what, how long should they  **Dr. Nirali Jain:** yeah. Like what does it look like? So I've had patients that come back, you know, in my fellowship training I did a, a couple research projects on patients that came back to pursue an embryo transfer, um, after chemotherapy agent. And basically compared them to how they did, um, [00:25:00] compared to patients that didn't have cancer and just froze their embryos or froze their eggs and then came back to pursue a transfer and. **Dr. Nirali Jain:** I think the, the most reassuring thing from the preliminary data that we have is saying that there's no difference in pregnancy rates and no difference in life birth,  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** of whether they had chemotherapy or not. After freezing those eggs and going through fertility preservation.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Um, in terms of where your body needs to be, I think the oncologist, we, we wait for their green light. **Dr. Nirali Jain:** We wait for their signal to say, you know, she's safe to carry a pregnancy.  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** And then once we do that, we basically treat you like any other patient. So if you're coming in for a cycle, if you're having periods, then it's reasonable to try a natural cycle protocol, wait for your body to naturally ovulate an egg. **Dr. Nirali Jain:** And instead of obviously hoping that egg will fertilize, we, um, use a corpus luteum. We use the progesterone from the corpus luteum to really support this embryo being implanted into the uterus. Um. Yeah. [00:26:00] And then there's also another side. I mean, some patients don't get their periods back and they always ask like, what if I never get my period back? **Dr. Nirali Jain:** What if I'm just like in menopause because of the chemotherapy agents? And for that, we can start you on a synthetic protocol or basically an estrogen dependent protocol where you take an estrogen pill for a certain number of days. We monitor your lining, then we start progesterone, um, to support your hormones from that perspective instead of relying on your ovaries to release the progesterone that they need, um, and then doing the embryo transfer a few, few days after progesterone starts. **Dr. Nirali Jain:** So there's definitely different protocols depending on where your menstrual health is at after the chemotherapy or after the cancer treatment. Um, but it's important to kind of just know that. That there's options. It doesn't mean that it's the end of the road if you all of a sudden stop getting your period. **Michelle Oravitz:** Yeah, for sure. I mean, 'cause you, technically speaking, you can really control a lot of that. More so for transfers  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** Retrievals really is kind of like what [00:27:00] eggs you have, what the quality is. But people can be in complete menopause and you guys can still control their cycles for transfer, which is kind of. A huge difference  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** in the  **Dr. Nirali Jain:** exactly. That's exactly right. Yeah. **Michelle Oravitz:** interesting. Any other, um, new, new things that you're, you guys are excited about? I always like to hear about like the new and upcoming things  **Dr. Nirali Jain:** Of course.  **Michelle Oravitz:** actually before, which I thought was fascinating. Yeah.  **Dr. Nirali Jain:** I feel like there's always like updates and, and new data and things like that coming out, but just know, I think it's important for patients to know, like we're constantly, we're, the reason I chose to even pursue this field was because it's new. Right. There's something that we are discovering every day, every year, and that's what makes our, our conferences so important to attend, um, to really just stay up to date. **Dr. Nirali Jain:** Um, but we are, uh, constantly updating our embryology standards, the way we thaw our eggs, and the success rate associated with a thaw and [00:28:00] how we treat our embryos and the media that we use, right? Like, so we're really thinking about the basic science perspective every single day, and that's what makes this field so unique. **Michelle Oravitz:** It is really awesome. And so do you guys specialize specifically on, um. Egg freezing and, and I mean specific fertility preservation in patients that do that have cancer that are going through treatments, do you guys specialize specifically in that? I mean, I know you do range  **Dr. Nirali Jain:** Yeah. Yeah, because it's such a small community, we all have our own niches and we all kind of have our own interests and  **Michelle Oravitz:** Yeah.  **Dr. Nirali Jain:** no like specific training. There are a couple courses that you take that I took in in training as well, just to kind of understand what it sounds like to, I. Council of fertility preservation, patient with and without cancer. **Dr. Nirali Jain:** Um, and then, you know, you kind of just learn by experience and you form a niche for something that you're passionate about. 'cause that's what makes you, you know, really thorough in, in your treatment. [00:29:00] So that's one of my interests. Um, and, but I would say,  **Michelle Oravitz:** training for that. It's just like  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** just know how to treat that in  **Dr. Nirali Jain:** exactly.  **Michelle Oravitz:** especially if you're interested in doing that.  **Dr. Nirali Jain:** Exactly. That's exactly right. It's kind of, it just comes with the experience comes with your mentors and who you're surrounded by, and everyone kind of helps each other get to that point. But there are several specialists in our practice at RMA that specialize specifically in fertility preservation in cancer patients. **Dr. Nirali Jain:** So we have a close communication with our oncologist and they know who to refer to within the practice because everyone has their own little interests.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** Um, definitely. I, like I said, I really enjoy picking your brain because it's a lot of fun for me. I, I do  **Dr. Nirali Jain:** Totally.  **Michelle Oravitz:** acupuncture, so  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** and I, I think that it's just so crazy that our fields don't work together. I mean, we kind of do, but I think, I just feel like it would be so great  **Dr. Nirali Jain:** exactly.[00:30:00]  **Michelle Oravitz:** the expertise because you guys have immense. Benefits like in, in, uh, technology and incredible innovations and, and then the natural aspect of really understanding the, the body. And I, I just think that it would work so amazing together if it was more of like a thing. 'cause it, I know in China they actually combine the two  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** eastern.  **Dr. Nirali Jain:** Yeah, I mean I think that that's so important and there is data that shows, you know, there's actually a recent study that came out just a few weeks ago on the benefits of acupuncture for fertility patients. And we know that, I mean, I recommend it to all of my patients, specifically the day of the embryo transfer. **Dr. Nirali Jain:** We, luckily, we offer it on site at RMA and we have acupuncturists that come in and, and do a session before and after the embryo transfer, and I think. A lot of that is targeted towards stress relief. But I also think that holistically it's important to feel at your best when we're doing something that's so crucial to your, to your health. **Dr. Nirali Jain:** So to really focus on the diet, focus on stress relief, [00:31:00] focus on meditation, yoga, whatever it takes to get to your best wellbeing when you're going through fertility treatments, um, is so important. So I appreciate  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** like you that really specialize in the other side of. Of this, because I do consider it still part of the holistic medicine that we need to really maximize success for our patients. **Michelle Oravitz:** Awesome. Well,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** Jane, this is such a pleasure Of talking to you. You've given us some, so much great information and we've definitely dived into a, do a topic that I don't typically, I haven't yet spoken about. But, um, that being said, it's such an important topic to talk about. And thank you so much for coming on today. **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** course. **Michelle Oravitz:** I get off, how can people find you?  **Dr. Nirali Jain:** That's a great question. So I have, um, a social media page. I, it's called Expert nc. So like EGG,  **Michelle Oravitz:** I  **Dr. Nirali Jain:** um, expert nc. Try, tried to make it a little bit humorous. Um, but I'm all over social [00:32:00] media and would love to hear from anyone that is listening. I, you know, every, every day I get different, um, dms and I'm happy to respond. **Dr. Nirali Jain:** I love hearing about everyone else's. Stories and things like that. Um, so that is kind of my main, main social media platform. Um, and then through like RMA and Reproductive Medical Associates, we also have a YouTube channel. We have an Instagram page, um, of our office available, um, as well that is public. **Dr. Nirali Jain:** So you can find us pretty easily if you just kind of hit Google. But um, yeah, I'm kind of developing my social media platform as the expert and I hope it grows.  **Michelle Oravitz:** Love it. Great.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** was such a pleasure talking to you. Thank you. so much **Dr. Nirali Jain:** Thank you. **Michelle Oravitz:** today.  **Dr. Nirali Jain:** Of course. Thank you so much for having me.  [00:33:00]   

Employee turnover is expensive—and preventable. In this episode of Behind The Numbers With Dave Bookbinder, we're tackling the hidden costs of turnover and the ROI of investing in your people. Dave is joined by Francie Jain, founder of Terawatt, a B2B marketplace for group coaching that Francie describes as “Airbnb for executive coaching.” Francie unpacks how scalable group coaching can help organizations drive learning, build psychological safety, and improve employee retention. The conversation explores the measurable and intangible impacts of turnover and burnout—and why professional development is the key to tackling both. You'll learn: How to calculate ROI on learning and development initiatives Why burnout is an organizational issue—not just an individual one Real-world examples of how coaching drives financial and cultural gains How leaders can foster engagement, empowerment, and better communication If you're looking for actionable ways to improve employee experience while improving your bottom line, this episode is for you. ----more----About Francie Jain: Francie Jain believes supporting people to achieve their potential creates a ripple effect for every community. After a career in alternative asset marketing (match-making for hedge funds), she became obsessed with the lack of professional support for individuals at crossroads. She founded Terawatt to make it easy to be great.   Terawatt is Francie's third for-profit endeavor. Before Terawatt, Francie founded a community that helped people with career change, Nxt Chptr, and prior to Nxt Chptr, a third party marketing consultancy, West River Partners, that raised capital for Emerging Markets-based equity hedge funds. About the Host: Dave Bookbinder is known as an expert in business valuation and he is the person that business owners and entrepreneurs reach out to when they need to know what their most important assets are worth. Known as a collaborative adviser, Dave has served thousands of client companies of all sizes and industries.  Dave is the author of two #1 best-selling books about the impact of human capital (PEOPLE!) on the valuation of a business enterprise called The NEW ROI: Return On Individuals & The NEW ROI: Going Behind The Numbers.  He's on a mission to change the conversation about how the accounting world recognizes the value of people's contributions to a business enterprise, and to quantify what every CEO on the planet claims: “Our people are this company's most valuable asset.” Dave's book, A Valuation Toolbox for Business Owners and Their Advisors: Things Every Business Owner Should Know, was recognized as a top new release in Business and Valuation and is designed to provide practical insights and tools to help understand what really drives business value, how to prepare for an exit, and just make better decisions. He's also the host of the highly rated Behind The Numbers With Dave Bookbinder business podcast which is enjoyed in more than 100 countries.

Send us a textFarming the Revolution captures a mass movement in vivid close-up, as 12 million farmers challenge the Indian government, forcing it to retract its unjust farm laws. Farming the Revolution will be screening at this year's Sydney Film Festival (SFF) on June 5th & 7th. This film is also a part of Collection: Focus on Nishta Jain screening The Golden Thread and Gulabi Gang.Note: this interview is audio only. For other video interviews check out our YouTube playlist.Website | Rotten Tomatoes | Linktree | Youtube | Twitter | Instagram

This week, we are revisiting a conversation between Lightspeed partner Michael Mignano and Arvind Jain, the founder and CEO of Glean about the evolution of AI-assisted enterprise search.Arvind shares what insights helped to start Glean's journey in 2019, how the company leveraged transformer-based models early on, and how Glean developed the market for this product. They also talk about competition, the technical aspects of integrating Glean across SaaS platforms, and the monumental impact of ChatGPT on the industry. Episode Chapters(00:00) Introduction (01:15) Why Arvind Created Glean to Solve Enterprise Search Problems(03:50) Technical Foundations: Building Glean with Transformers(09:04) Product Market Fit and Early Challenges(12:16) The Impact of ChatGPT and Market Evolution(13:42) Glean's Architecture and Model Integration(17:58) The Future of AI in Enterprises(27:52) Leadership, Competition, and Company Culture(35:48) Reflections and Lessons from Rubrik to Glean(41:15) Lightning Round and Closing RemarksStay in touch:www.lsvp.comX: https://twitter.com/lightspeedvpLinkedIn: https://www.linkedin.com/company/lightspeed-venture-partners/Instagram: https://www.instagram.com/lightspeedventurepartners/Subscribe on your favorite podcast app: generativenow.coEmail: generativenow@lsvp.comThe content here does not constitute tax, legal, business or investment advice or an offer to provide such advice, should not be construed as advocating the purchase or sale of any security or investment or a recommendation of any company, and is not an offer, or solicitation of an offer, for the purchase or sale of any security or investment product. For more details please see lsvp.com/legal.

In this Heartline Echo Episode, Dr. Shikha Jain discusses her journey into medicine and her multifaceted career. The conversation highlights systemic changes needed in healthcare, such as pay transparency, diverse leadership, and supporting women's career development. Dr. Jain emphasizes the importance of personal joy, career advancement, and family balance in her professional decisions, offering insights into navigating a demanding field while driving meaningful change. Join Dr. Shikha Jain on this inspiring journey as she shares her insights, strategies, and unwavering passion for creating a more equitable future for women in medicine. Immerse yourself in a conversation that promises to ignite your own inner fire, challenging you to embrace your authentic voice and become an agent of positive transformation. "We have to realize that we need to make decisions, even if people are going to keep asking us to do stuff because we're good at what we do. At some point, you have to say no because it's not worth it." -Dr. Shikha Jain As a GI oncologist, Director of Communication Strategy at the University of Illinois Cancer Center, and the founder of the Women in Medicine Summit, Dr. Jain has dedicated herself to a mission that transcends mere professional development. Her unwavering commitment lies in dismantling the very foundations that have hindered women's progress, paving the way for a healthcare ecosystem that truly embraces equity, diversity, and inclusivity. In this thought-provoking conversation, you'll discover: Innovative strategies to address systemic barriers, such as pay transparency, diverse leadership pipelines, and supportive career pathways. The transformative impact of the Women in Medicine Summit, a premier CME conference that equips attendees with practical skills, personal growth opportunities, and a powerful network of allies. Register here. Insights into Dr. Jain's personal journey, from her early inspiration to her relentless pursuit of empowering women and driving positive change within healthcare systems. The Resources Mentioned in this episode are: Visit Dr. Shikha Jain's ⁠website⁠ to learn more about her and to check out her ⁠podcast⁠.  Register for the ⁠Women in Medicine Summit⁠ occurring September 13th to 14th at the Drake Hotel in Chicago and consider attending the ⁠2025 Women in Medicine European River Retreat⁠. Connect with Dr. Shikha Jain: ⁠X⁠ ⁠LinkedIn⁠ ⁠Facebook⁠ ⁠Instagram⁠

SHOW NOTES: Definitions:Jiva (soul): essence of every living thing, eternal and consciousKevala: omniscience, absolute knowledge of reality; enlightenment that terminates samsaraDigambara: one of the main Jain sects; characterized by monastic practice of nudityShvetambara: larger of the two main Jain sects; characterized by monastic practice of wearing white Jina: "conqueror" or one who has overcome samsaraTirthankara: a "bridge builder" or "maker of the ford"; one who has crossed over from the captivity of samsara to the world of enlightenment and freedom from rebirthFive Great VowsDo nor harm any living thing.Speak the truth.Do not steal.Be chaste.Renounce all possessions.Vaughn, Lewis. Anthology of world religions: sacred texts and contemporary perspectives. Oxford University Press, 2017.Partridge, Christopher, and Tim Dowley. A Brief Introduction to Jainism and Sikhism. 1st ed. Vol. 5 of Brief Introductions to World Religions. Minneapolis, Minnesota: Fortress Press, 2019. Copy the citation to clipboardGough, Ellen. “Jainism: An Introduction - By Jeffery D. Long.” Religious Studies Review 36, no. 1 (2010): 97. Copy the citation to clipboard

So many leaders are burned out—checking all the boxes, meeting expectations, and still feeling stuck. Pallavi Jain wants to change that. As a seasoned HR executive and the creator of the Lead From Within program, she helps people step out of survival mode and reconnect with who they truly are—and how they want to lead and be known.In this episode of Branding Room Only, Paula Edgar sits down with Pallavi to explore why personal branding starts with self-leadership. They trace Pallavi's path from engineer to HR leader and unpack how her lived experiences—and inner transformation—shaped both her leadership philosophy and personal brand.Pallavi shares her signature ATM Framework—a practical, powerful approach to building presence, taking responsibility, and making intentional choices. They also explore how identity, memory, and even generational trauma can shape—or distort—how we show up in the world.This isn't a conversation about polished personas or performative leadership. It's about doing the real, internal work to build an authentic, resilient brand—rooted in clarity, alignment, and joy.1:12 – Pallavi's personal branding definition, self-description, favorite childhood quote, and energizing songs5:37 – The influence of Pallavi's upbringing on her brand and her career path from engineering to HR leadership8:30 – What led to the creation of Pallavi's Lead From Within program and ATM framework10:17 – Pallavi's tips for building your personal branding with authenticity and the impact of lived experiences on your brand 17:33 – The premise of Pallavi's program and framework, and how they help strengthen personal growth and empowerment21:03 – The three steps of the ATM framework and the benefit of consistently implementing it 29:20 – Common mistakes from not leading from within that lead to burnout and ineffectiveness36:18 – How traumatic memories can impact your perception and those of generations to follow40:20 – Why organizations should incorporate the ATM framework45:18 - A breakthrough Pallavi achieved from using her framework and how to start tapping into the power within you49:15 – What Pallavi will never do to compromise her personal brand and the magic she brings to a standing-room-onlyMentioned In Lead From Within to Stop Surviving and Start Leading with Pallavi JainPallavi Jain The A.T.M. Framework For Personal Growth | Pallavi Jain | TEDxWilmingtonSalon2025 Intention and Goal Setting WebinarLearn More About Paula's Personal Branding Strategy Session OfferHelp others find the podcast. Subscribe and leave a quick review.Join Paula's newsletter for expert tips and exclusive content! Subscribe HereSponsor for this episodePGE Consulting Group LLC empowers individuals and organizations to lead with purpose, presence, and impact. Specializing in leadership development and personal branding, we offer keynotes, custom programming, consulting, and strategic advising—all designed to elevate influence and performance at every level.Founded and led by Paula Edgar, our work centers on practical strategies that enhance professional development, strengthen workplace culture, and drive meaningful, measurable change.To learn more about Paula and her services, go to www.paulaedgar.com or contact her at info@paulaedgar.com, and follow Paula Edgar and the PGE Consulting Group LLC on LinkedIn.

25 years after Joanne Harris introduced readers to the soothing delights of Chocolat, she's released her new book Vianne. It's the prequel that explains how her heroine found her way into the world of high end French confectionery. A new exhibition at the British Museum sheds light on the provenance of popular images of the Hindu god Ganesha, the Buddha and Jain enlightened teachers. We talk to curator Sushma Jansari about Ancient India: living traditions, alongside expert in Indian ritual art, Professor Partha Mitter.The 2025 Cannes Film Festival is well underway. We get the latest from Daily Telegraph Critic, Robbie Collin.Rumours abound about the planned axing of the Government Department for Digital, Culture, Media & Sport. Alison Cole, head of the Cultural Policy Unit think tank, tells us what this could mean for the arts.Presenter Samira Ahmed. Producer Harry Graham

Arvind Jain joins Sarah and Elad on this episode of No Priors. Arvind is the founder and CEO of Glean, an AI-powered enterprise search platform. He previously co-founded Rubrik and spent over a decade as an engineering leader at Google. In this episode, Arvind shares how LLMs are transforming enterprise search, why most tools in the space have failed, and the opportunity to build apps powered by internal knowledge. He discusses how much customization is still needed on top of foundation models, what made building Glean uniquely challenging compared to Arvind's previous ventures, and what's next for the company. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @jainarvind Show Notes: 0:00 Introduction 0:58 How LLMs are changing search 2:05 Building out Glean's platform 5:09 Why most search companies failed 8:41 Out of the box vs. bespoke models  10:26 Creating apps on top of internal knowledge 15:34 User behaviors & insights  19:11 Unique challenges of building Glean  21:51 Product-led growth vs. enterprise sales 25:00 Succeeding in traditionally bad markets  27:08 What Glean is excited to build next

In this episode, host Shikha Jain, MD, speaks with Abiola Ibraheem, MD, about the role culture plays in improving global oncology, launching the Best of ASCO in Africa and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Ibraheem 1:42 •    The interview 3:02 •    How did you get where you are today?  3:28 •    Can you tell me more about Aortic Africa and your role within the organization? 5:41 •    What are some challenges you have encountered in doing this work, both locally and internationally? 7:33 •    How have you navigated the nuances of global oncology in other countries?  9:51 •    Did you get any pushback when you decided to create these global relationships and inroads? How did you navigate receiving different perspectives on your work? 12:10 •    What are you hoping to achieve with these efforts in global oncology? 16:28 •    Where did the idea for a Best of ASCO Africa come from, and what do you hope to achieve with the event? 17:41 •    Jain and Ibraheem on the importance of providing other countries with tools to implement and drive global change. 22:54 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 27:29 •    How to contact Ibraheem 28:09 •    Thanks for listening 29:07 Abiola Ibraheem, MD, is a board-certified medical oncologist and assistant professor at the University of Illinois Chicago. Her journey in medicine began in Nigeria, where she earned her MBBS degree from Olabisi Onabanjo University. She then completed her internal medicine residency at Morehouse School of Medicine, focusing on racial health care disparities. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Ibraheem can be reached via email at abiolai@uic.edu. Learn more about Best of ASCO Africa, as well as how to sign up for in-person or virtual attendance, happening June 27 & 28 in Addis Abba, Ethiopia. Disclosures: Jain and Ibraheem report no relevant financial disclosures. 

For today's show, special guest host Chrissy Tracey—chef, forager, and author of “Forage & Feast”—fills in for host Kerry Diamond for a vibrant conversation with cookbook authors Mehreen “Reenie” Karim and Srishti Jain. Reenie, known from “Next Level Chef” and Bon Appétit, is now executive editor of the new “Make It Plant-Based” cookbook series and the author of “Make It Plant-Based! Southern.” She's joined by Srishti, a NYC-based supper club host and the author of “Make It Plant-Based! Indian.”Reenie and Srishti join Chrissy Tracey to dive into what it takes to build a cookbook from the ground up, celebrate the versatility of plant-based cuisine, and share stories from the heart of today's food media landscape.Thank you to Gustiamo for supporting Radio Cherry Bombe.Subscribe to Cherry Bombe's print magazine. Visit cherrybombe.com for subscriptions and show transcripts. More on Chrissy: Instagram, “Forage & Feast” cookbookMore on Reenie: Instagram, website, "Make It Plant-Based! Southern" cookbookMore on Srishti: Instagram, “Make It Plant-Based! Indian” cookbookMore on Kerry: Instagram

Le 9 mars 1964 devant l'assemblée générale de l'ONU, Miriam Makeba vient lancer un appel pour que l'Afrique du Sud soit condamnée et surtout sanctionnée pour sa politique d'apartheid. Vous vous souvenez peut-être de cette chanson de Jain il y a quelques années qui rendait hommage à Miriam Makeba : « Je veux voir ton combat parce que tu incarnes la beauté véritable des droits humains », « I want to see you fight- Because you are the real beauty of human right », un hommage enthousiaste 50 ans plus tard à celle qui lit son papier, émue, devant l'Assemblée des nations ce jour de 1964. L'égalité de toutes et tous en dignité et en droit est l'un des crédos de l'ONU depuis sa création. Avec l'instauration du régime d'Apartheid en Afrique du Sud en 1948, la nouvelle organisation se trouvait face à un défi de taille. Chloé Maurel a travaillé sur ces grands discours de personnalités à la tribune de l'ONU qui jalonnent son histoire. Réf. Bibliographique : Chloé Maurel, Histoire des idées des Nations unies. L'ONU en 20 notions (Paris, L'Harmattan, 2015).